Data / Form D filings / Arix Bioscience plc
Arix Bioscience plc: Form D filings
Arix Bioscience plc, a health care company in London, United Kingdom, filed 3 Form D notices with the SEC between 2017 and 2018. The latest, on April 4, 2018, reports $21.4 million sold of a $121.8 million offering to 5 investors.
Find out what Arix Bioscience plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 BERKELEY SQUARE, London, United Kingdom, W1J 6
- Phone
- 44(0)20 7290 1050
- Industry
- Other Health Care
- Entity type
- Other (Public limited company in the United Kingdom)
- Incorporated in
- United Kingdom
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1700449
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2018 | New notice | $121,778,626 | $21,438,354 | $100,340,272 | 5 | Mar 20, 2018 | sec.gov |
| Mar 13, 2017 | Amendment | $124,560,000 | $17,943,967 | $106,616,033 | 4 | Feb 22, 2017 | sec.gov |
| Mar 9, 2017 | New notice | $121,000,000 | $17,506,964 | $103,493,036 | 4 | Feb 22, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JONATHAN PEACOCK | Executive Officer, Director | |
| JOHN HUTTON OF FURNESS | Director | |
| FRANZ HUMER | Director | |
| MEGHAN MAIR FITZGERALD | Director | |
| JOSEPH ANDERSON | Executive Officer, Director | |
| GILES MAIR KERR | Director | |
| TREVOR JONES | Director | |
| DAVID U'PRICHARD | Director | |
| JAMES RAWLINGSON | Executive Officer, Director | |
| CHRISTOPHER EVANS | Executive Officer, Director |
Every Form D from the week of Apr 2, 2018 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Arix Bioscience plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.